Patents by Inventor Kenneth Lee Moya

Kenneth Lee Moya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein
    Patent number: 10722554
    Abstract: The invention relates to the use of a homeoprotein of the bicoid family, in particular of the Otx family, for enhancing the survival of cultivated retinal ganglion neurones, and for preventing or treating ganglion neuron degeneration particularly occurring in glaucoma.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: July 28, 2020
    Assignees: Centre National de la Recherche Scientifique, Ecole Normale Superieure
    Inventors: Alain Prochiantz, Kenneth Lee Moya
  • INHIBITION OF THE SYNTHESIS OF BETA-APP OR OF THE ACTIVITY OF THE A-BETA PEPTIDE IN THE CHOROID PLEXUS
    Publication number: 20180142012
    Abstract: The invention relates to the treatment of neurodegenerative diseases, in particular Alzheimer's disease, by inhibition of the synthesis of ?APP or of the activity of the A? peptide in the choroid plexus.
    Type: Application
    Filed: December 4, 2017
    Publication date: May 24, 2018
    Applicants: Centre National de la Recherche Scientifique, Collège de France, Institut National de la Santé et de la Recherche Médicale (INSERM)
    Inventors: Ariel Di Nardo, Kenneth Lee Moya, Karen Arnaud, Alain Prochiantz
  • Inhibition of the synthesis of beta-app or the activity of the A-? peptide in the choroid plexus
    Patent number: 9868783
    Abstract: The invention relates to the treatment of neurodegenerative diseases, in particular Alzheimer's disease, by inhibition of the synthesis of ?APP or of the activity of the A? peptide in the choroid plexus.
    Type: Grant
    Filed: July 4, 2014
    Date of Patent: January 16, 2018
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, COLLEGE DE FRANCE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Ariel Di Nardo, Kenneth Lee Moya, Karen Arnaud, Alain Prochiantz
  • INHIBITION OF THE SYNTHESIS OF BETA-APP OR OF THE ACTIVITY OF THE A-BETA PEPTIDE IN THE CHOROID PLEXUS
    Publication number: 20160159889
    Abstract: The invention relates to the treatment of neurodegenerative diseases, in particular Alzheimer's disease, by inhibition of the synthesis of ?APP or of the activity of the A? peptide in the choroid plexus.
    Type: Application
    Filed: July 4, 2014
    Publication date: June 9, 2016
    Applicants: Centre National de la Recherche Scientifique, Collège de France, Institut National de la Santé et de la Recherche Médicale (INSERM)
    Inventors: Ariel Di Nardo, Kenneth Lee Moya, Karen Arnaud, Alain Prochiantz